- Home
- YYAI vs IBIO Comparison
YYAI vs IBIO Comparison
Compare YYAI & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YYAI
- IBIO
- Stock Information
- Founded
- YYAI 2015
- IBIO 2008
- Country
- YYAI Hong Kong
- IBIO United States
- Employees
- YYAI N/A
- IBIO N/A
- Industry
- YYAI
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- YYAI
- IBIO Health Care
- Exchange
- YYAI NYSE
- IBIO Nasdaq
- Market Cap
- YYAI 13.7M
- IBIO 15.9M
- IPO Year
- YYAI N/A
- IBIO N/A
- Fundamental
- Price
- YYAI $0.89
- IBIO $0.71
- Analyst Decision
- YYAI
- IBIO Strong Buy
- Analyst Count
- YYAI 0
- IBIO 3
- Target Price
- YYAI N/A
- IBIO $4.87
- AVG Volume (30 Days)
- YYAI 186.5K
- IBIO 5.3M
- Earning Date
- YYAI 08-05-2025
- IBIO 05-02-2025
- Dividend Yield
- YYAI N/A
- IBIO N/A
- EPS Growth
- YYAI N/A
- IBIO N/A
- EPS
- YYAI N/A
- IBIO N/A
- Revenue
- YYAI N/A
- IBIO $375,000.00
- Revenue This Year
- YYAI N/A
- IBIO $36.00
- Revenue Next Year
- YYAI N/A
- IBIO N/A
- P/E Ratio
- YYAI N/A
- IBIO N/A
- Revenue Growth
- YYAI N/A
- IBIO 650.00
- 52 Week Low
- YYAI $0.35
- IBIO $0.64
- 52 Week High
- YYAI $18.96
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- YYAI 51.78
- IBIO 37.70
- Support Level
- YYAI $0.75
- IBIO $0.68
- Resistance Level
- YYAI $0.92
- IBIO $1.04
- Average True Range (ATR)
- YYAI 0.11
- IBIO 0.12
- MACD
- YYAI -0.00
- IBIO -0.00
- Stochastic Oscillator
- YYAI 33.33
- IBIO 7.89
About YYAI CONNEXA SPORTS TECHNOLOGIES IN
Connexa Sports Technologies Inc operates in the sports equipment and technology business. It is a connected sports company delivering products, technologies, and services across the Watch, Play, Learn commercial and subscription-as-a-service activities in sports. The company's offerings include Slinger Launcher, which is comprised of a portable tennis ball launcher, a portable padel tennis ball launcher, and a portable pickleball launcher. Through Gameface, it provides AI technology and performance analytics.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.